MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rpth.2022.100025

Медицинская библиотека · Research and practice in thrombosis and haemostasis · 2022

Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function.

Rieder Marina, Baldus Niklas, Stallmann Daniela, Jeserich Maren, Goller Isabella, Wirth Luisa, Pollmeier Luisa, Hofmann Maike, Bode Christoph, Busch Hans-Joerg, Schmid Bonaventura, Gauchel Nadine, Scharf Rüdiger E, Duerschmied Daniel, Lother Achim, Krauel Krystin

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Conflicting results have been reported on platelet activity ex vivo and responsiveness in vitro among patients with COVID-19 with or without thromboembolic complications.

OBJECTIVES

To assess platelet reactivity in patients with moderate disease at early stages of COVID-19.

METHODS

We performed a prospective, descriptive analysis of 100 consecutive patients presenting with suspected SARS-CoV-2 infection at University Medical Center Freiburg during the first or second wave of the pandemic. Following polymerase chain reaction testing and compliance with study inclusion criteria, 20 SARS-CoV-2-positive and 55 SARS-CoV-2-negative patients (serving as patient controls) were enrolled. In addition, 15 healthy subjects were included. Platelet reactivity was assessed using whole-blood impedance aggregometry and flow cytometry in response to various agonists.

RESULTS

Platelet aggregation was significantly impaired in the patients with COVID-19 compared with that in the patient controls or healthy subjects. The reduced platelet responsiveness in the patients with COVID-19 was associated with impaired activation of GPIIb/IIIa (αIIbβ3). In contrast, low expression of P-selectin at baseline and intact secretion upon stimulation in vitro suggest that no preactivation in vivo, leading to "exhausted" platelets, had occurred. The proportion of circulating platelet-neutrophil complexes was significantly higher in the patients with COVID-19 (mean ± SD, 41% ± 13%) than in the patient controls (18% ± 7%; 95% CI, 11.1-34.1; P = .0002) or healthy subjects (17% ± 4%; 95% CI, 13.8-33.8; P < .0001). An analysis of neutrophil adhesion receptors revealed upregulation of CD11b (α-subunit of αMβ2) and CD66b (CEACAM8) but not of CD162 (PSGL-1) in the patients with COVID-19.

CONCLUSION

Despite reduced platelet responsiveness, platelet-neutrophil complexes are increased at early stages of moderate disease. Thus, this cellular interaction may occur during COVID-19 without preceding platelet activation.

Для цитирования: Rieder Marina, Baldus Niklas, Stallmann Daniela, Jeserich Maren, Goller Isabella, Wirth Luisa, Pollmeier Luisa, Hofmann Maike, Bode Christoph, Busch Hans-Joerg, Schmid Bonaventura, Gauchel Nadine, Scharf Rüdiger E, Duerschmied Daniel, Lother Achim, Krauel Krystin. Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function.. Research and practice in thrombosis and haemostasis. 2022. DOI: 10.1016/j.rpth.2022.100025.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.